Main Topics:

- Clinical Innovation in Patient-Centered Care
- Therapeutic Advances and Disease Management
- Emergency Pharmacy and Crisis Management
- Advances in Research Reshaping the Future of Health Care
- Evolving Pharmaceutical Care in Community Pharmacy
- Capacity Building Global Health Diplomacy

According to the World Health Organization, non-communicable diseases (NCDs) make up over 60% of the deaths worldwide, many of which occur before the age of 70. Cardiovascular diseases are the most critical NCDs worldwide with diabetes as a major cardiovascular risk factor. Cardiovascular diseases impose medical, social and public health problems that increase the economic burden on patients, healthcare systems and national economies. Pharmacists have an important role to play as part of a multidisciplinary healthcare team approach focused on the prevention, early detection, disease state management and optimisation of therapy regimens.

Learning objectives:

• To get an overview of the different roles that pharmacists can play in the management of cardiovascular diseases in terms of prevention, screening, patient referral, disease state management and treatment optimisation
• To learn about the FIP reference paper on NCDs launched in April (including selected international best practices/examples)
• To develop the knowledge and skills for developing professional services in this area.

According to the World Health Organization, non-communicable diseases (NCDs) make up over 60% of the deaths worldwide, many of which occur before the age of 70. Cancer of all types is of tremendous concern globally. Expanding preventative measures by addressing risk factors and adequate screening is of utmost importance to reduce incidence rates and improve survival rates. In addition Pharmacotherapy for treatment of cancer is often complex, with many medication-related adverse events.

Cancer treatment frequently results in the prescribing of additional therapy to manage adverse effects, including short-term and long-term therapies for gastrointestinal, dermatological, neurological, psychological, and endocrinological adverse effects. Both community and hospital pharmacists can play important and complementary roles in cancer prevention, screening and treatment optimisation. These will be described in this webinar.

Learning objectives:

• To get an overview of the different roles that community and hospital pharmacists can play in the management of cancer in terms of prevention, screening, patient referral, disease state management and treatment optimisation
• To learn about the FIP reference paper on NCDs launched in April (including selected international best practices/examples)
• To develop the knowledge and skills for developing professional services in this area.

the International Conference on Advances in Pharmaceutical Drug Development, Quality Control and Regulatory Sciences (DDRS 2020) will be organised on Margaret Island, Budapest, 17-19 March, 2020 on the occasion of the 250^th anniversary of the foundation of Semmelweis University in Budapest, Hungary. 

The conference will address new trends in pharmaceutical, regulatory science of biological and non-biological complex drugs (NBCDs) and the challenges for their correct use.

The 25th EAHP Congress 2020 will focus on the latest advances in technologies that will shape the way how pharmaceutical care in hospitals will be delivered in the upcoming decades. Artificial intelligence, mHealth, 3D printing, personalised medicine, all of these will influence our work towards the optimal outcomes for our patients and have the potential to change our workflows profoundly. The Congress will also cover the ongoing challenges in our work, like tackling antimicrobial resistance, delivering seamless care, raising the quality of hospital pharmacy compounding, advances in clinical pharmacy or the role of hospital pharmacists in the multidisciplinary teams in hospital and on the interface with community or outpatient settings, just to name a few.

The scientific programme of the Congress is also tailored to the needs of individual hospital pharmacists and their interest groups as the Congress offers the possibility to choose between many parallel sessions, keynote presentations, workshops and symposia, and plenty of networking opportunities.

This is your opportunity to join experts from around the world in Gothenburg to share experience and ideas and to learn from each other and to discuss the role of new technology in pharmacy.

The 3^rd edition of Phar-East is happening in Singapore from 31 March to 1 April 2020. It is your chance to network with over 1,000 leading experts from across Asia and gain insights about the latest trends in the pharma and biotech industry. The conference will feature 5 premium theatres focusing on immunotherapy, regulatory affairs, Pharma 4.0, market access, biotech investments, clinical trials and an all-new track – Bio Data. Running alongside the conference, will be an all-new innovation and start-up zone, where we will be bringing in more than 80 start-ups in the pharma and biotech industry to share their latest technologies and solutions. Get the latest updates here or download the event brochure here

Join us at Asia’s Pharma & Biotech Festival and be a part of Asia’s fastest growing pharmaceutical and biotech market! Book your tickets now

Come to the 2020 FIP congress in Seville, Spain, where pharmacy practitioners, pharmaceutical scientists and educators from around the world will discuss and help you prepare for these new technologies that will empower our profession.

Previous industrial revolutions liberated humans from reliance on animal power, made mass production possible and brought digital capabilities to billions. This latest industrial revolution is, however, fundamentally different. It is characterised by a range of technologies that are fusing the physical, digital and biological worlds, impacting on all disciplines, economies and industries, and even challenging ideas about what it means to be human.

Digitalisation is already allowing the keeping of structured patient records, facilitating electronic prescribing, dispensing and administration of medicines, automating the handling of medicines in the supply chain, and providing tools for monitoring the efficacy and safety of medicines in use. Further advances will enable pharmacists to interact with patients through the creation of a common platform for accessing data and information in new, more efficient way.